直肠指检与血清前列腺特异性抗原在前列腺癌早期检测中的比较:一项纳入6630名男性的多中心临床试验结果
这项前瞻性多中心临床试验在6个大学中心纳入6630名50岁及以上男性志愿者,比较直肠指检与血清前列腺特异性抗原(PSA)早期检测前列腺癌的效能。PSA>4 μg/l或直肠指检可疑者行四象限活检。PSA检出肿瘤的比例显著高于直肠指检(82% vs 55%,p=0.001),两者联合可提高器官局限癌检出率。
要点
- PSA检出264例癌症中的216例(82%),直肠指检检出146例(55%),差异显著(p=0.001)。
- PSA阳性预测值为32%,直肠指检为21%;癌症检出率分别为4.6%和3.2%,联合为5.8%。
- 若活检要求经直肠超声可疑,近40%肿瘤将被漏诊。
核心结论
- PSA联合直肠指检可提高前列腺癌早期检出率。
- 若PSA>4 μg/l或直肠指检可疑,即使经直肠超声无异常发现,也应考虑行前列腺活检。
研究设计与样本
- 前瞻性多中心临床试验,在6个大学中心纳入6630名50岁及以上男性志愿者。
- 行PSA测定(Hybritech Tandom-E或Tandem-R检测)和直肠指检。
- PSA>4 μg/l或直肠指检可疑者行四象限活检,即使经直肠超声无癌症可疑区域。
主要发现
- 15%的男性PSA>4 μg/l,15%直肠指检可疑,26%任一或两项检查可疑。
- 共行1167例活检,检出264例癌症。
- PSA检出216/264例癌症(82%),直肠指检检出146/264例(55%),p=0.001。
- 癌症检出率:直肠指检3.2%,PSA 4.6%,两者联合5.8%;阳性预测值:PSA 32%,直肠指检21%。
- 160例行根治性前列腺切除术及病理分期者中,114例(71%)为器官局限癌;PSA检出85例(75%),直肠指检检出64例(56%),p=0.003;两者联合较单用直肠指检提高器官局限癌检出78%(50/64例)。
临床怎么用
- 作者结论认为,PSA联合直肠指检可提高前列腺癌早期检出。
- 作者建议,若PSA>4 μg/l或直肠指检可疑癌症,即使经直肠超声无异常发现,也应考虑行前列腺活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To compare the efficacy of digital rectal examination and serum prostate specific antigen (PSA) in the early detection of prostate cancer, we conducted a prospective clinical trial at 6 university centers of 6,630 male volunteers 50 years old or older who underwent PSA determination (Hybritech Tandom-E or Tandem-R assays) and digital rectal examination. Quadrant biopsies were performed if the PSA level was greater than 4 μg./l. or digital rectal examination was suspicious, even if transrectal ultrasonography revealed no areas suspicious for cancer. The results showed that 15% of the men had a PSA level of greater than 4 μg./l., 15% had a suspicious digital rectal examination and 26% had suspicious findings on either or both tests. Of 1,167 biopsies performed cancer was detected in 264. PSA detected significantly more tumors (82%, 216 of 264 cancers) than digital rectal examination (55%, 146 of 264, p = 0.001). The cancer detection rate was 3.2% for digital rectal examination, 4.6% for PSA and 5.8% for the 2 methods combined. Positive predictive value was 32% for PSA and 21% for digital rectal examination. Of 160 patients who underwent radical prostatectomy and pathological staging 114 (71%) had organ confined cancer: PSA detected 85 (75%) and digital rectal examination detected 64 (56%, p = 0.003). Use of the 2 methods in combination increased detection of organ confined disease by 78% (50 of 64 cases) over digital rectal examination alone. If the performance of a biopsy would have required suspicious transrectal ultrasonography findings, nearly 40% of the tumors would have been missed. We conclude that the use of PSA in conjunction with digital rectal examination enhances early prostate cancer detection. Prostatic biopsy should be considered if either the PSA level is greater than 4 μg./l. or digital rectal examination is suspicious for cancer, even in the absence of abnormal transrectal ultrasonography findings.
引用
- Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men. J Urol. 2016. PMID: 28012755. doi:10.1016/j.juro.2016.10.073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。